Panacea Biotec Limited
NSE:PANACEABIO.NS
333.14 (INR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,591.7 | 4,599.5 | 6,592.23 | 6,176.49 | 5,371.86 | 4,523.36 | 5,860.3 | 5,448 | 6,530.8 | 6,871.9 | 5,153.7 | 6,084.9 | 7,100.9 | 11,437.8 | 9,001.498 | 7,881.719 | 8,413.435 | 8,423.543 | 5,419.015 | 3,279.273 |
| Cost of Revenue
| 4,164 | 2,526.6 | 3,000.07 | 2,285.33 | 1,745.74 | 2,027.09 | 2,103.64 | 1,750.3 | 2,158.1 | 2,891.3 | 2,140 | 2,634.1 | 4,066.6 | 5,319.5 | -501.408 | -452.622 | -4.589 | 123.484 | 12.956 | -346.951 |
| Gross Profit
| 1,427.7 | 2,072.9 | 3,592.16 | 3,891.16 | 3,626.12 | 2,496.27 | 3,756.66 | 3,697.7 | 4,372.7 | 3,980.6 | 3,013.7 | 3,450.8 | 3,034.3 | 6,118.3 | 9,502.907 | 8,334.342 | 8,418.024 | 8,300.059 | 5,406.059 | 3,626.224 |
| Gross Profit Ratio
| 0.255 | 0.451 | 0.545 | 0.63 | 0.675 | 0.552 | 0.641 | 0.679 | 0.67 | 0.579 | 0.585 | 0.567 | 0.427 | 0.535 | 1.056 | 1.057 | 1.001 | 0.985 | 0.998 | 1.106 |
| Reseach & Development Expenses
| 0 | 328.2 | 358.03 | 390.17 | 107.08 | 255.83 | 144.6 | 425.23 | 452.8 | 83.2 | 86.2 | 84 | 0 | 753.1 | 753.063 | 669.944 | 541.856 | 505.012 | 280.926 | 140.562 |
| General & Administrative Expenses
| 0 | 158.4 | 276.71 | 274.67 | 202.59 | 239.76 | 229.9 | 189 | 263.8 | 1,412.1 | 298.5 | 420.7 | 884.7 | 0 | 0 | 0 | 0 | 4,287.117 | 3,194.865 | 2,265.726 |
| Selling & Marketing Expenses
| 0 | 231.4 | 480.84 | 511.81 | 428.08 | 312.65 | 369.83 | 276.1 | 350.8 | 256 | 460.9 | 488.7 | 576.5 | 611.2 | 474.656 | 458.23 | 492.3 | 342.398 | 251.151 | 203.908 |
| SG&A
| 1,995.4 | 389.8 | 757.55 | 786.48 | 630.67 | 552.41 | 599.73 | 465.1 | 614.6 | 1,668.1 | 2,661.4 | 2,739.1 | 1,461.2 | 611.2 | 474.656 | 458.23 | 492.3 | 4,629.514 | 3,446.017 | 2,469.634 |
| Other Expenses
| 258 | 516.6 | 33.97 | 20.16 | 8.67 | 20.85 | 5.11 | 66.9 | 84.2 | 24.9 | 4,467.7 | 5,120.3 | -2.9 | 2,688.6 | 6,719.057 | 7,722.862 | 5,354.637 | 873.873 | 551.524 | 478.945 |
| Operating Expenses
| 1,995.4 | 3,443.7 | 4,123.59 | 3,523.96 | 3,205.52 | 3,543.98 | 3,374.7 | 3,192 | 3,806.9 | 3,992 | 4,467.7 | 5,120.3 | 4,051.8 | 4,052.9 | 7,946.775 | 8,851.037 | 6,388.793 | 6,008.399 | 4,278.467 | 3,089.14 |
| Operating Income
| -567.7 | -1,027.39 | -484.18 | 427.33 | 429.26 | -1,105.51 | 381.96 | -567.2 | -189.3 | -994.1 | -1,109.6 | -2,530.6 | -1,017.5 | 2,063.7 | 1,556.132 | -516.695 | 2,029.231 | 2,291.66 | 1,127.592 | 537.084 |
| Operating Income Ratio
| -0.102 | -0.223 | -0.073 | 0.069 | 0.08 | -0.244 | 0.065 | -0.104 | -0.029 | -0.145 | -0.215 | -0.416 | -0.143 | 0.18 | 0.173 | -0.066 | 0.241 | 0.272 | 0.208 | 0.164 |
| Total Other Income Expenses Net
| 582.5 | 1,155.44 | 14,977.74 | -1,869.79 | -2,141.46 | 1,591.66 | -1,043.35 | -1,072.9 | -755.1 | -982.7 | 344.4 | -861.1 | -1,581 | -521.7 | -428.424 | -349.969 | -152.373 | -173.102 | -140.75 | -134.623 |
| Income Before Tax
| 14.8 | 128 | 14,488.09 | -1,442.46 | -1,712.2 | 486.15 | -661.39 | -567.2 | -189.3 | -994.1 | -1,109.6 | -2,530.6 | -2,598.5 | 1,543.7 | 1,127.708 | -866.664 | 1,876.858 | 2,118.557 | 986.842 | 402.461 |
| Income Before Tax Ratio
| 0.003 | 0.028 | 2.198 | -0.234 | -0.319 | 0.107 | -0.113 | -0.104 | -0.029 | -0.145 | -0.215 | -0.416 | -0.366 | 0.135 | 0.125 | -0.11 | 0.223 | 0.252 | 0.182 | 0.123 |
| Income Tax Expense
| 29.8 | 465.5 | 3,709.05 | 19.57 | 166.4 | 77.07 | 98.58 | 37.1 | 19.2 | 30.8 | 16.8 | -187.6 | -541.9 | 218.9 | 416.679 | 206.739 | 587.041 | 642.108 | 394.376 | 129.544 |
| Net Income
| -11.7 | -337.5 | 10,783.15 | -1,476.96 | -1,942.67 | 377.27 | -759.97 | -644.6 | -182.9 | -1,065.1 | -1,121.3 | -2,342.8 | -2,056.6 | 1,324.8 | 724.12 | -659.925 | 1,289.817 | 1,476.449 | 592.467 | 272.916 |
| Net Income Ratio
| -0.002 | -0.073 | 1.636 | -0.239 | -0.362 | 0.083 | -0.13 | -0.118 | -0.028 | -0.155 | -0.218 | -0.385 | -0.29 | 0.116 | 0.08 | -0.084 | 0.153 | 0.175 | 0.109 | 0.083 |
| EPS
| -0.19 | -5.51 | 176.05 | -24.11 | -31.72 | 6.16 | -12.41 | -10.52 | -2.99 | -17.39 | -18.31 | -38.25 | -33.58 | 22.98 | 12.24 | -9.89 | 19.51 | 23.84 | 9.57 | 3.91 |
| EPS Diluted
| -0.19 | -5.51 | 176.05 | -24.11 | -31.72 | 6.16 | -12.41 | -10.52 | -2.99 | -17.39 | -18.31 | -38.25 | -33.58 | 22.98 | 11.46 | -9.26 | 18.25 | 21.85 | 9.36 | 3.91 |
| EBITDA
| -200.6 | -463 | -31.14 | 868.22 | 904.74 | -825.08 | 887.46 | 1,116 | 1,294.5 | 648 | -2,513.9 | -806.1 | -246.9 | 2,820.7 | 2,217.102 | 247.271 | 2,496.809 | 2,670.474 | 1,319.258 | 692.524 |
| EBITDA Ratio
| -0.036 | -0.101 | -0.005 | 0.141 | 0.168 | -0.182 | 0.151 | 0.205 | 0.198 | 0.094 | -0.488 | -0.132 | -0.035 | 0.247 | 0.246 | 0.031 | 0.297 | 0.317 | 0.243 | 0.211 |